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Abstract The possible role of nitric oxide (NO) in brain
mitochondrial maturation was studied. Within the first 5 min
after birth, a sharp increase in ATP concentrations was observed,
coinciding with an increase in mitochondrial complex II-III
(succinate-cytochrome c reductase) activity, while complex I
(NADH-CoQ1 reductase) and complex IV (cytochrome c
oxidase) activities remained unchanged. Under the same
circumstances, cGMP concentrations were increased by 5 min
after birth, correlating significantly with ATP concentrations.
Since ATP concentrations also correlated significantly with
mitochondrial complex II-III activity, these three parameters
may be associated. Inhibition of NO synthase activity brought
about by the administration of Ng-nitro-L-arginine monomethyl
ester to mothers prevented the postnatal increase in cGMP and
ATP levels and complex II-III activity. These results suggest
that early postnatal mitochondrial maturation in the brain is a
NO-mediated process.
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1. Introduction
During the postnatal period the rat brain undergoes a peri-
od of rapid growth and maturation which requires a good
supply of energy as the cells divide, enlarge in size and devel-
op their full adult metabolic activity (for a review, see [1]).
Under these circumstances, the provision of energy in the
form of ATP is a prime requirement for the developing brain
to carry out its normal functions. Consequently, the acqui-
sition of fully developed mitochondria after birth is essential
to enable newborn mammals to successfully adapt to extra-
uterine life. Brain mitochondrial function has been studied
during the ¢rst month of extrauterine life [2^5], but no evi-
dence concerning the mechanisms and factors involved in
mitochondrial maturation in the brain is available.
Within the CNS, NO appears to be an important signal-
ling molecule in the transduction pathway leading to increased
intracellular cGMP concentrations. This ability to increase
brain cGMP levels suggests that NO is involved in the reg-
ulation of important metabolic pathways in the brain (for a
review, see [6^8]). In addition, a role for NO in the develop-
ment of the nervous system has also been suggested [9^11]. In
this context, nitric oxide synthase (NOS) is present in brain
tissues during the embryonic and early postnatal stages [10^
13]. Thus, Western blot analysis of NOS isoform proteins has
revealed that the amount of brain NOS protein increases
around birth in the rat [10], together with brain NOS activity
[10,11,13] and NO biosynthesis [14].
The mitochondrion is known to be a target organelle for
the action of NO (reviewed in [15,16]). Under certain patho-
logical circumstances NO synthesis may be excessive and
then NO becomes neurotoxic, causing mitochondrial dys-
function and hence a state of energy de¢ciency [15].
The aim of this work was to investigate the possible rela-
tionship between NO synthesis around birth and the abrupt
onset of mitochondrial function in the brain immediately after
delivery.
2. Materials and methods
2.1. Materials
Ng-Nitro-L-arginine monomethyl ester (L-NAME) and ubiquinine-
5 (coenzyme Q1) were obtained from Sigma Chem. Co. (St. Louis,
MO, USA). Cytochrome c (Boehringer Mannheim, Germany) was
reduced with sodium ascorbate immediately before use and passed
through Sephadex G-25M (PD-10 columns, Pharmacia LKB, Uppsa-
la, Sweden) to remove ascorbate. Other substrates, enzymes, coen-
zymes and standard analytical laboratory reagents were purchased
from Sigma, Boehringer or Merck (Darmstadt, Germany).
2.2. Animals
Albino Wistar rats fed on a stock laboratory diet (w/v, carbohy-
drate 58.7%, protein 17.0%, fat 3.0%, plus added salts and vitamins)
and of known gestational age were used for the experiments. Virgin
females weighing 225^250 g were caged overnight with males. Con-
ception was considered to occur at 01.00 h and was con¢rmed the
next morning by the presence of spermatozoa in vaginal smears. To
inhibit NOS, L-NAME was given to pregnant rats in their drinking
water at a concentration of 0.1, 0.3 or 1 mg/ml throughout the last
week of gestation, as previously described [17]. Fetuses were delivered
on day 21.5 of gestation (21.7 day for full gestation) by rapid hyster-
ectomy after cervical dislocation of the mother.
Immediately after delivery, newborns were carefully wiped, their
umbilical cords were tied and cut and they were kept in an incubator
at 37‡C under a continuous stream of water-saturated air without
feeding. All newborns were killed by decapitation at the times indi-
cated in the ¢gures (5 min, 1 h or 2 h) and their whole brains were
rapidly (6 2 s) freeze-clamped in liquid nitrogen and kept frozen
(320‡C) until analysis.
2.3. Enzyme activity determinations
For the determination of mitochondrial respiratory chain complex
activities, brains were homogenized in 0.1 M potassium phosphate
bu¡er, pH 7.4, to a ¢nal protein concentration of V8 mg/ml. Enzyme
activities were determined in the homogenates using a Hitachi U2000
spectrophotometer (Hitachi Ltd., Tokyo, Japan). Complex I (NADH-
CoQ1 reductase; EX 1.6.99.3) activity was measured as described in
Ragan et al. [18]. The activity of complex II-III (succinate-cytochrome
c reductase; EC 1.8.3.1) was determined following the method of
King [19]. Complex IV (cytochrome c oxidase; EC 1.9.3.1) activity
was determined as described by Wharton and Tzagolo¡ [20]. All en-
zyme activities were expressed as nmol per min per mg of protein,
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except for cytochrome c oxidase, which was expressed as the ¢rst-
order rate constant (k, per min per mg of protein).
2.4. ATP and cGMP determinations
For nucleotide determinations, frozen brains were weighed and im-
mediately homogenized in 30 volumes of 0.3 M HClO4. Extracts were
neutralized with 0.5 M KHCO3 and centrifuged, the supernatants
being used for analysis. cGMP was measured using a commercially
available radioimmunoassay kit (Amersham International, UK) and
following the manufacturer’s instructions. ATP was determined by the
luciferin/luciferase chemiluminescence method using a commercially
available kit (Sigma) following the manufacturer’s instructions. Nu-
cleotide concentrations were expressed as pmol of cGMP or Wmol of
ATP per g of brain wet weight.
2.5. Protein determinations
Protein concentrations were determined in brain homogenates by
the method of Lowry et al. [21], using bovine serum albumin as stand-
ard.
2.6. Statistical analysis
Results are expressed as means þ S.E.M. for the number of new-
borns, indicated in the legends, coming from at least three di¡erent
pregnant rats. Statistical analysis of the results was determined by
Student’s t test.
3. Results
Immediately after birth (5 min), we observed a signi¢cant
increase (31%, P6 0.001) in ATP concentrations in the rat
brain (Fig. 1), reaching 75% of the ATP concentration found
at 2 h of extrauterine life (Fig. 1). This prompted us to inves-
tigate the activities of the mitochondrial respiratory chain
complexes under the same circumstances. Fig. 2 shows that
complex II-III (succinate-cytochrome c reductase) activity in-
creased by about 29% at 5 min after birth, following a devel-
opmental pattern similar to that found for ATP concentra-
tions (Fig. 1). In fact, a linear correlation (r = 0.982) between
Fig. 1. ATP concentrations in rat brain during the early postnatal
period. Term fetuses (0 h; without breathing) or 5 min, 1 h or
2 hold newborns were killed and their brains were immediately re-
moved and frozen for ATP analysis as described in Section 2. Re-
sults are mean þ S.E.M. values from 14^26 newborns from 4^10 dif-
ferent pregnant rats. ***P6 0.001 compared to previous value.
Fig. 2. Mitochondrial respiratory chain complex activities in rat brain during the early postnatal period. Term fetuses (0 h; without breathing)
or 5 min, 1 h or 2 hold newborns were killed and their brains were immediately removed and frozen for enzymatic analysis as described in Sec-
tion 2. The lower panel shows the correlation between complex II-III activities and ATP concentrations at di¡erent times around birth. Results
are mean þ S.E.M. values from 10^17 newborns from 4^6 di¡erent pregnant rats. Each value in the correlation plot represents the mean þ
S.E.M. from 4^6 newborns from each pregnant rat. ***P6 0.001 compared to previous value.
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complex II-III activity and ATP concentration was found in
the brain during the postnatal period, at least up to 1 h after
birth (Fig. 2). In contrast, no changes in the activities of
complex I (NADH-CoQ1 reductase) and complex IV (cyto-
chrome c oxidase) were found during the postnatal period
(Fig. 2). Also, the activity of citrate synthase remained un-
changed in these circumstances (170 þ 8.75 and 185 þ 5.35
nmol/min per mg protein at 0 h and 5 min, respectively),
suggesting that the postnatal increase in complex II-III activ-
ity (Fig. 2) would not be due to an increase in the number of
mitochondria.
NOS is expressed transiently in the CNS during the peri-
natal period [13,22,23], coinciding with an increase in NO
biosynthesis [14]. We therefore investigated the role of NO
synthesis during the early postnatal period. In this sense, since
the cGMP concentration is a well-known index of the rate of
NO synthesis [24], we measured cGMP concentrations during
the ¢rst 5 min of extrauterine life. Fig. 3 shows that brain
cGMP concentrations increased signi¢cantly from the fetal (0
h) to the neonatal (5 min) periods concurrently with those of
ATP (Fig. 1). In order to quantitatively evaluate both phe-
nomena, a linear regression analysis of the data was per-
formed; this gave a highly signi¢cant (P6 0.001) correlation
(r = 0.694) between ATP and cGMP concentrations in the
brain under our experimental conditions (Fig. 3).
In order to further con¢rm the possible role of NO in
Table 1
E¡ect of L-NAME administration on mitochondrial respiratory chain complex activities in the brain of 5 min old newborn rats
Condition Mitochondrial enzyme activities
Complex I Complex II-III Complex IV CS
Control 10.02 þ 0.42 3.31 þ 0.15 1.32 þ 0.05 185 þ 5.39
L-NAME (0.1 mg/ml) 10.48 þ 0.62 2.75 þ 0.24* 1.38 þ 0.08 180 þ 3.88
L-NAME (1 mg/ml) 11.00 þ 0.97 2.46 þ 0.21** 1.40 þ 0.07 188 þ 7.27
Di¡erent concentrations (0.1 or 1 mg/ml) of L-NAME were administered to pregnant rats in their drinking water during the last week of gesta-
tion. Enzyme activities were measured in the brains of newborns as described in Section 2. Results are mean þ S.E.M. values from 7^17 new-
borns from 3^6 di¡erent pregnant rats and are expressed as nmol/min per mg of protein, except complex IV activity, which is expressed as k/
min per mg of protein. CS, citrate synthase.
*P6 0.05, **P6 0.01 compared to control value.
Fig. 3. cGMP concentrations in rat brain during the early postnatal
period. Term fetuses (0 h; without breathing) or 5 min, 1 h of
2 hold newborns were killed and their brains were immediately re-
moved and frozen for cGMP and ATP analysis as described in Sec-
tion 2. In the inset, results on cGMP are mean þ S.E.M. values
from 20^26 newborns from 7^10 di¡erent pregnant rats.
***P6 0.001 compared to 0 h value.
Fig. 4. E¡ect of L-NAME administration on ATP and cGMP con-
centrations in the newborn rat brain. Di¡erent concentrations (0.1,
0.3 or 1 mg/ml) of L-NAME were administered to pregnant rats in
their drinking water during the last week of gestation. Term fetuses
(0 h; without breathing) or 5 min old newborns were killed and
their brains were immediately removed and frozen for cGMP and
ATP analysis as described in Section 2. Results of cGMP and ATP
are mean þ S.E.M. values from 12^26 newborns from 3^10 di¡erent
pregnant rats. ***P6 0.001, **P6 0.01, *P6 0.05 compared to
term fetuses (0 h) from the same experimental group.
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postnatal mitochondrial maturation, L-NAME, a potent NOS
inhibitor, was administered to pregnant rats at increasing
doses during the last week of gestation [17] and brain ATP
concentrations were measured in 5 min old newborns. Our
results show that L-NAME administration prevented the
postnatal increase in cGMP concentration in a dose-depend-
ent fashion, the increase being abolished at 0.3 mg/ml L-
NAME (Fig. 4). Likewise, the administration of 0.1 mg/ml
L-NAME to the mothers prevented the postnatal increase in
brain ATP concentrations as compared to the values found in
newborns from untreated mothers (Fig. 4). The postnatal in-
crease in brain ATP concentrations was completely prevented
when L-NAME was administered at 0.3 mg/ml (Fig. 4). The
correlation between ATP and cGMP concentrations in the
brains of newborns from untreated and 0.1, 0.3 or 1 mg/ml
L-NAME-treated mothers is shown in Fig. 4. A signi¢cant
(P6 0.001) linear correlation (r = 0.997) was observed,
although this disappeared when L-NAME was administered
at the highest concentration of 1 mg/ml (Fig. 4).
Table 1 shows the activities of the mitochondrial respiratory
chain complexes and citrate synthase in the brains of 5 min
old newborns from untreated (control) and 0.1 or 1 mg/ml L-
NAME-treated mothers. The administration of L-NAME to
the mothers signi¢cantly decreased the activity of mitochon-
drial complex II-III as compared to the values found in new-
borns from untreated mothers. However, complex I, complex
IV and citrate synthase activities remained unchanged by the
treatment (Table 1).
4. Discussion
Although previous works have studied brain mitochondrial
function during the ¢rst month of extrauterine life [2^5], no
evidence concerning brain mitochondrial maturation during
the ¢rst hours after birth, when neurons represent 95^98%
of brain cells [25], is available. Our results show that complex
II-III activity, but not complex I or complex IV activities,
increased signi¢cantly at 5 min after birth and this activity
persisted during the ¢rst 2 h of extrauterine life (Fig. 2). It
is noteworthy that the activity found for complex II-III at
5 min after birth was similar to the observed in mature cul-
tured neurons [26,27]. This suggests that the maturation of
mitochondria occurs in the brain immediately after birth.
The developmental pattern of complex II-III activity (Fig. 2)
was similar to that found for ATP concentrations (Fig. 1).
Thus, brain ATP concentrations increased sharply 5 min after
birth and remained high throughout the early postnatal peri-
od (Fig. 1). In addition, a linear correlation between complex
II-III activity and ATP concentrations (Fig. 2) was observed
during the ¢rst hour after birth, suggesting that both phenom-
ena might be related. If so, the increases in ATP concentra-
tions and in complex II-III activity immediately after birth
might be due to postnatal mitochondrial maturation. In
fact, the activities of glycolytic enzymes are very low in the
rat brain at birth [28^30], suggesting that under these circum-
stances ATP synthesis is mainly due to mitochondrial activity.
Since it is well accepted that cGMP concentrations can be
regarded as an index of endogenous NO formation [24], the
increase in cGMP concentrations observed by us shortly after
birth (Fig. 3, inset) suggests that NO synthesis is enhanced
under these circumstances. In agreement with this, it has been
demonstrated that NOS is present in brain tissues during the
embryonic and early postnatal stages [10^13]. In addition,
brain NOS activity rises signi¢cantly at birth [10,11,13] to-
gether with NO biosynthesis [14], suggesting that NO may
play a role in the transition from fetal to neonatal life.
The highly signi¢cant (P6 0.001) correlation observed be-
tween ATP and cGMP concentrations in the neonatal rat
brain suggests that both parameters may be associated. In
fact, the administration of L-NAME, a potent NOS inhibitor,
decreased the postnatal increase in ATP concentration in a
dose-dependent way, the increase being completely blocked
when 0.3 mg/ml L-NAME was administered (Fig. 4). These
results suggest that NO synthesis is mandatory for the post-
natal increase in ATP concentrations. Moreover, the admin-
istration of L-NAME also prevented the postnatal increase in
complex II-III activity (Table 1; see Fig. 2 for 0 h value),
suggesting that NO mediates postnatal mitochondrial matu-
ration in the brain.
Immediately after birth there is an important enhancement
of oxygen availability that coincides with an increase in oxi-
dative metabolism [31,32]. Since the synthesis of NO from
arginine in the reaction catalyzed by NOS requires oxygen as
a compulsory co-substrate (reviewed in [33]), the early in-
crease in oxygen availability [32] may trigger NO synthesis.
If so, oxygen may be the signal for mitochondrial maturation,
NO acting as a second messenger.
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